Treatment of late stage adenocarcinoma

Dr Nitesh Rohatgi- Max Healthcare, New Delhi, India
Treatment of late stage adenocarcinoma ( Dr Nitesh Rohatgi- Max Healthcare, New Delhi, India )
13 Feb 2020

Cancer registry in Tanzania and the lung cancer control program

Dr Nestory Masalu - Bugando Medical Centre, Mwanza City, Tanzania
Cancer registry in Tanzania and the lung cancer control program ( Dr Nestory Masalu - Bugando Medical Centre, Mwanza City, Tanzania )
7 Feb 2020

The value of cancer care in low-resource settings

Dr Bishal Gyawali - Queen's University, Kingston, Canada
The value of cancer care in low-resource settings ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
7 Feb 2020

Where have we got to with cancer treatment?

Prof Alexander Eggermont - Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands
Where have we got to with cancer treatment? ( Prof Alexander Eggermont - Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands )
27 Jan 2020

Immunotherapy for NSCLC: Recent advances and future directions

Prof Neal Ready - Duke University School of Medicine, Durham, USA
Immunotherapy for NSCLC: Recent advances and future directions ( Prof Neal Ready - Duke University School of Medicine, Durham, USA )
27 Jan 2020

Immunotherapy and targeted agents for elderly lung cancer patients

Dr Lore Decoster - University Hospital Brussels, Brussels, Belgium
Immunotherapy and targeted agents for elderly lung cancer patients ( Dr Lore Decoster - University Hospital Brussels, Brussels, Belgium )
28 Nov 2019

Challenges in treating elderly lung cancer patients

Prof Mike Jaklitsch - Harvard Medical School, Boston, USA
Challenges in treating elderly lung cancer patients ( Prof Mike Jaklitsch - Harvard Medical School, Boston, USA )
28 Nov 2019

Checkmate 227: Final analysis for the non small cell lung cancer trial

Prof Sanjay Popat - The Royal Marsden Hospital, London, UK
Checkmate 227: Final analysis for the non small cell lung cancer trial ( Prof Sanjay Popat - The Royal Marsden Hospital, London, UK )
7 Oct 2019

PROMISE-meso trial results: Pembrolizumab vs chemotherapy for advanced pleural mesothelioma

Prof Sanjay Popat - The Royal Marsden Hospital, London, UK
PROMISE-meso trial results: Pembrolizumab vs chemotherapy for advanced pleural mesothelioma ( Prof Sanjay Popat - The Royal Marsden Hospital, London, UK )
7 Oct 2019

Highlights from ESMO 2019

Prof Josep Tabernero - ESMO President
Highlights from ESMO 2019 ( Prof Josep Tabernero - ESMO President )
4 Oct 2019

Pembrolizumab plus platinum-based chemotherapy for metastatic NSCLC

Dr Luis Paz-Ares - Hospital Universitario Doce de Octubre, Madrid, Spain
Pembrolizumab plus platinum-based chemotherapy for metastatic NSCLC ( Dr Luis Paz-Ares - Hospital Universitario Doce de Octubre, Madrid, Spain )
4 Oct 2019

AMG 510: A novel molecule targeting KRAS G12C mutant solid tumours

Prof Marwan Fakih - City of Hope National Medical Center, Duarte, USA
AMG 510: A novel molecule targeting KRAS G12C mutant solid tumours ( Prof Marwan Fakih - City of Hope National Medical Center, Duarte, USA )
4 Oct 2019